Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT04680923Not ApplicableCompleted

Efficacy of CPPLAI in Laparoscopic Sleeve Gastrectomy Patients

Role: lead

NCT05596604Completed

"Awareness, Preconception, and Fear of Epidural Analgesia Among Childbearing Women in Saudi Arabia."

Role: lead

NCT04565093Not ApplicableCompleted

Efficacy of iPACK After Unilateral TKA

Role: lead

NCT04716439Unknown

Effect of TIVA With Magnesium Sulfate on IONM in Patients Undergoing Spine Surgery

Role: lead

NCT04673500Not ApplicableCompleted

Assessment of Pain on Propofol Injection.

Role: lead

NCT04357535Completed

Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives

Role: collaborator

NCT02998125Completed

An Exploration of Outcomes Post-total Knee Arthroplasty in Middle East

Role: collaborator

NCT04010110Completed

Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics

Role: collaborator

All 8 trials loaded